DRUG · Mapped RxNorm record
Avastin
Normalized identity: Avastin View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer
NCT00043823
Study summary
ClinicalTrials.govAvastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Tarceva
Normalized identity: Tarceva View linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Lung Cancerverified · MONDO: lung cancer
Interventions
AvastinDRUG · verified · RxNorm: Avastin
TarcevaDRUG · verified · RxNorm: Tarceva
Sponsors & collaborators
M.D. Anderson Cancer Centerlead sponsor
Genentech, Inc.collaborator
Vanderbilt-Ingram Cancer Centercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00043823 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.